Editorial: Exploring the Potential of PSMA-PET Imaging on Personalized Prostate Cancer Treatment

Front Oncol. 2022 Feb 2:12:832747. doi: 10.3389/fonc.2022.832747. eCollection 2022.

Harun Ilhan¹, Trevor Royce^{2

3}, Xuefeng Qiu⁴, Constantinos Zamboglou^{5

6}

¹ Department of Nuclear Medicine, University Hospital, Ludwigs-Maximilian Universitaet (LMU) Munich, Munich, Germany.
² Department of Radiation Oncology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, United States.
³ Flatiron Health, New York, NY, United States.
⁴ Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
⁵ Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
⁶ German Oncology Center, European University Cyprus, Limassol, Cyprus.

No abstract available

Keywords: personalized and precision medicine (PPM); prostate cancer; prostate specific membrane antigen (PSMA); radiotherapy; surgery.

Publication types